English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/101413
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Highly functionalized 2-oxopiperazine-based peptidomimetics: An approach to PAR1 antagonists

AuthorsValdivielso, Ángel M. CSIC; Ventosa-Andrés, Pilar CSIC; Tato, Francisco; Fernández-Ibañez, M. Ángeles; Pappos, Ioannis; Tsopanoglou, Nikos E.; García-López, M. Teresa CSIC; Gutiérrez-Rodríguez, Marta CSIC ORCID ; Herranz, Rosario CSIC ORCID
KeywordsPAR1 antagonists
α-Amino nitriles
Platelet antiaggregant activity
Issue Date2013
CitationEuropean Journal of Medicinal Chemistry 70: 199- 204 (2013)
AbstractA series of pseudodipeptide-based chiral 1,3,4,5-tetrasubstituted-2- oxopiperazines has been designed and synthesized as potential PAR1 antagonists. These highly functionalized piperazines were synthesized from aromatic and basic amino acid derived Ψ[CH(CN)NH]pseudodipeptides through a four step pathway that involves reduction of the cyano group to build the 2-oxopiperazine ring, followed by selective functionalization at the N4-, N 1-positions, and at the exocyclic moiety at position C5. This regioselective functionalization required the fine tuning of reaction conditions. All new compounds were screened as inhibitors of human platelet aggregation induced by the PAR1 agonist SFLLRN and as cytotoxic agents in human cancer cell lines. Some of the compounds displayed moderate PAR1 antagonist activity, while, others were cytotoxic at μM concentration. No correlation was observed between both types of activities.
Identifiersdoi: 10.1016/j.ejmech.2013.09.058
issn: 0223-5234
e-issn: 1768-3254
Appears in Collections:(IQM) Artículos
Files in This Item:
File Description SizeFormat 
Eur J Med Chem-2013.pdf1,56 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.